Aldh2(E487k) Mutation Increases Protein Turnover and Promotes Murine Hepatocarcinogenesis
Shengfang Jin,Jiang Chen,Lizao Chen,Gavin Histen,Zhizhong Lin,Stefan Gross,Jeffrey Hixon,Yue Chen,Charles Kung,Yiwei Chen,Yufei Fu,Yuxuan Lu,Hui Lin,Xiujun Cai,Hua Yang,Rob A. Cairns,Marion Dorsch,Shinsan M. Su,Scott Biller,Tak W. Mak,Yong Cang
DOI: https://doi.org/10.1073/pnas.1510757112
2015-01-01
Abstract:Mitochondrial aldehyde dehydrogenase 2 (ALDH2) in the liver removes toxic aldehydes including acetaldehyde, an intermediate of ethanol metabolism. Nearly 40% of East Asians inherit an inactive ALDH2*2 variant, which has a lysine-for-glutamate substitution at position 487 (E487K), and show a characteristic alcohol flush reaction after drinking and a higher risk for gastrointestinal cancers. Here we report the characterization of knockin mice in which the ALDH2(E487K) mutation is inserted into the endogenous murine Aldh2 locus. These mutants recapitulate essentially all human phenotypes including impaired clearance of acetaldehyde, increased sensitivity to acute or chronic alcohol-induced toxicity, and reduced ALDH2 expression due to a dominant-negative effect of the mutation. When treated with a chemical carcinogen, these mutants exhibit increased DNA damage response in hepatocytes, pronounced liver injury, and accelerated development of hepatocellular carcinoma (HCC). Importantly, ALDH2 protein levels are also significantly lower in patient HCC than in peritumor or normal liver tissues. Our results reveal that ALDH2 functions as a tumor suppressor by maintaining genomic stability in the liver, and the common human ALDH2 variant would present a significant risk factor for hepatocarcinogenesis. Our study suggests that the ALDH2*2 allele-alcohol interaction may be an even greater human public health hazard than previously appreciated.